New Long-Term Faricimab Data Boosts Drug’s Profile for nAMD, DME and RVO
A swathe of promising new data for Roche’s (Basel, Switzerland) Vabysmo (faricimab-svoa) at the virtual 21st Annual Angiogenesis, Exudation and…
Could Eye Drops Replace Injections? Experts provide insights into the prospects and challenges of using eye drops to treat retinal conditions
Highlighting recent studies and positive Phase 3 trial results, experts explored promising developments in retinal eye drops, addressing issues of…
latest posts